GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nirvana Life Sciences Inc (XCNQ:NIRV) » Definitions » FCF Yield %

Nirvana Life Sciences (XCNQ:NIRV) FCF Yield % : -13.06 (As of May. 27, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Nirvana Life Sciences FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Nirvana Life Sciences's Trailing 12-Month Free Cash Flow is C$-0.25 Mil, and Market Cap is C$1.93 Mil. Therefore, Nirvana Life Sciences's FCF Yield % for today is -13.06%.

The historical rank and industry rank for Nirvana Life Sciences's FCF Yield % or its related term are showing as below:

XCNQ:NIRV' s FCF Yield % Range Over the Past 10 Years
Min: -55.82   Med: 0   Max: 0
Current: -13.06


XCNQ:NIRV's FCF Yield % is ranked better than
52.25% of 1554 companies
in the Biotechnology industry
Industry Median: -14.415 vs XCNQ:NIRV: -13.06

Nirvana Life Sciences's FCF Margin % for the quarter that ended in Jan. 2024 was 0.00%.


Nirvana Life Sciences FCF Yield % Historical Data

The historical data trend for Nirvana Life Sciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nirvana Life Sciences FCF Yield % Chart

Nirvana Life Sciences Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Apr22 Apr23
FCF Yield %
Get a 7-Day Free Trial - - - -2.60 -32.62

Nirvana Life Sciences Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.56 -27.03 -24.88 -14.51 -1.47

Competitive Comparison of Nirvana Life Sciences's FCF Yield %

For the Biotechnology subindustry, Nirvana Life Sciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nirvana Life Sciences's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nirvana Life Sciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Nirvana Life Sciences's FCF Yield % falls into.



Nirvana Life Sciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Nirvana Life Sciences's FCF Yield % for the fiscal year that ended in Apr. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.333 / 1.02099
=-32.62%

Nirvana Life Sciences's annualized FCF Yield % for the quarter that ended in Jan. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.008 * 4 / 2.170485
=-1.47%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nirvana Life Sciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Nirvana Life Sciences FCF Yield % Related Terms

Thank you for viewing the detailed overview of Nirvana Life Sciences's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nirvana Life Sciences (XCNQ:NIRV) Business Description

Traded in Other Exchanges
N/A
Address
650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8
Nirvana Life Sciences Inc is focused on developing medical products and regimens that address addiction. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.

Nirvana Life Sciences (XCNQ:NIRV) Headlines

No Headlines